Inflammation may underlie the metabolic disorders of insulin resistance and type 2 diabetes. IκB kinase β (IKK-β, encoded by Ikbkb) is a central coordinator of inflammatory responses through activation of NF-κB. To understand the role of IKK-β in insulin resistance, we used mice lacking this enzyme in hepatocytes (IkbkbΔhep) or myeloid cells (IkbkbΔmye). IkbkbΔhep mice retain liver insulin responsiveness, but develop insulin resistance in muscle and fat in response to high fat diet, obesity or aging. In contrast, IkbkbΔmye mice retain global insulin sensitivity and are protected from insulin resistance. Thus, IKK-β acts locally in liver and systemically in myeloid cells, where NF-κB activation induces inflammatory mediators that cause insulin resistance. These findings demonstrate the importance of liver cell IKK-β in hepatic insulin resistance and the central role of myeloid cells in development of systemic insulin resistance. We suggest that inhibition of IKK-β, especially in myeloid cells, may be used to treat insulin resistance.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Kahn, B. B. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 92, 593–596 (1998).
Zimmet, P., Alberti, K. G. & Shaw, J. Global and societal implications of the diabetes epidemic. Nature 414, 782–787 (2001).
Kahn, B. B. & Flier, J. S. Obesity and insulin resistance. J Clin Invest 106, 473–81 (2000).
Klover, P. J., Zimmers, T. A., Koniaris, L. G. & Mooney, R. A. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52, 2784–2789 (2003).
Grimble, R. F. Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 5, 551–559 (2002).
Pickup, J. C. & Crook, M. A. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41, 1241–1248 (1998).
Pickup, J. C., Mattock, M. B., Chusney, G. D. & Burt, D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40, 1286–1292 (1997).
Festa, A., D'Agostino, R., Jr., Tracy, R. P. & Haffner, S. M. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51, 1131–1137 (2002).
Hotamisligil, G. S. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 27 Suppl 3, S53–S55 (2003).
Barnes, P. J. & Karin, M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066–1071 (1997).
Chen, L. W. et al. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9, 575–581 (2003).
Kim, J. K. et al. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest. 108, 437–446 (2001).
Yuan, M. et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673–1677 (2001).
Arena, F. P., Dugowson, C. & Saudek, C. D. Salicylate-induced hypoglycemia and ketoacidosis in a nondiabetic adult. Arch. Intern. Med. 138, 1153–1154 (1978).
Karin, M., Yamamoto, Y. & Wang, Q. M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3, 17–26 (2004).
Li, Z. W. et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189, 1839–1845 (1999).
Rohl, M. et al. Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance. J. Clin. Invest. 113, 474–481 (2004).
Maeda, S. et al. IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity 19, 725–737 (2003).
Greten, F. R. et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004).
Lovejoy, J. C. The influence of dietary fat on insulin resistance. Curr. Diab. Rep. 2, 435–440 (2002).
Hevener, A. L. et al. Muscle-specific Pparg deletion causes insulin resistance. Nat. Med. 9, 1491–1497 (2003).
Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432 (1994).
Koistinen, H. A. & Zierath, J. R. Regulation of glucose transport in human skeletal muscle. Ann. Med. 34, 410–418 (2002).
Whiteman, E. L., Cho, H. & Birnbaum, M. J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13, 444–451 (2002).
Li, Q., Van Antwerp, D., Mercurio, F., Lee, K. F. & Verma, I. M. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321–325 (1999).
Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81–S96 (2002).
Maeda, S. et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19, 725–737 (2003).
Virkamaki, A. & Yki-Jarvinen, H. Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134, 2072–2078 (1994).
Sugita, H. et al. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 282, E386–E394 (2002).
Cai, D. et al. Local and systemic insulin resistance due to hepatic activation of IKK-β and NF-kB. Nat. Med. 11, 183–190 (2005).
Cai, D. et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119, 285–298 (2004).
Samuel, V. T. et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279, 32345–32353 (2004).
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R. & Shulman, G. I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664–671 (2004).
Moore, K. J. et al. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat. Med. 7, 41–47 (2001).
Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821–1830 (2003).
Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003).
Miyazaki, Y., Pipek, R., Mandarino, L. J. & DeFronzo, R. A. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 27, 88–94 (2003).
Bruun, J. M., Pedersen, S. B., Kristensen, K. & Richelsen, B. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol. Cell. Endocrinol. 190, 91–99 (2002).
Patti, M. E. Gene expression in humans with diabetes and prediabetes: what have we learned about diabetes pathophysiology? Curr. Opin. Clin. Nutr. Metab. Care 7, 383–390 (2004).
Li, Q. & Verma, I. M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2, 725–734 (2002).
Leffert, H. L., Koch, K. S., Moran, T. & Williams, M. Liver cells. Methods Enzymol. 58, 536–544 (1979).
Arkan, M. C., Leonarduzzi, G., Biasi, F., Basaga, H. & Poli, G. Physiological amounts of ascorbate potentiate phorbol ester-induced nuclear-binding of AP-1 transcription factor in cells of macrophagic lineage. Free Radic. Biol. Med. 31, 374–382 (2001).
Hu, Y. et al. IKKα controls formation of the epidermis independently of NF-κB via a differentiation inducing factor. Nature 410, 710–714 (2001).
Research was supported by grants from the US National Institutes of Health to M.K. (ES06376), J.O. (DK33651), and A.H. (DK60484) and Italian Ministry of University to G.P. (FIRB2001, RBAU01JBH8). M.K. is an American Cancer Society Research Professor. M.C.A. was funded by a Mentor-Based Postdoctoral Fellowship from the American Diabetes Association to M.K.
The authors declare no competing financial interests.
About this article
Cite this article
Arkan, M., Hevener, A., Greten, F. et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat Med 11, 191–198 (2005). https://doi.org/10.1038/nm1185
Compartmentalized muscle redox signals controlling exercise metabolism – Current state, future challenges
Redox Biology (2020)
Journal of Dietary Supplements (2020)
Cell Communication and Signaling (2020)
Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice
PLOS ONE (2020)
The Targeted Impact of Flavones on Obesity-Induced Inflammation and the Potential Synergistic Role in Cancer and the Gut Microbiota